GenomeQuest & Beth Israel: Developing whole-genome analysis (WGA) applications for personalized health care
GenomeQuest, Inc., a global leader in sequence data management, and Beth Israel Deaconess Medical Center (BIDMC), a teaching hospital of Harvard Medical School, announced a two-year collaboration to develop whole-genome analysis (WGA) applications for personalized health care. The announcement was made during the opening session of the World Health Forum, held at Harvard Medical School.
- Introduction
Anthony Flynn, GenomeQuest CMO - Harry Glorikian
Founder, Scientia Advisors - Dr. Mark Boguski
BIDMC, Harvard Medical School - Richard Resnick
GenomeQuest CEO - Questions & Answers
- Harry Glorikian Interview
- Dr. Mark Boguski Interview
- Dr. Hendrik Heus Interview
Highlights